help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 9, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2100
A more recent version of this article appeared on November 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/11/6251    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meneilly, G. S.
Right arrow Articles by Elahi, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meneilly, G. S.
Right arrow Articles by Elahi, D.

Submitted on October 22, 2004
Accepted on August 1, 2005

Deconvolution analysis of rapid insulin pulses before and after six weeks of continuous subcutaneous administration of GLP-1 in elderly patients with type 2 diabetes

Graydon S. Meneilly, Johannes D. Veldhuis, and Dariush Elahi*

The Division of Geriatric Medicine, the Department of Medicine, University of British Columbia, Vancouver, BC (GSM); the Department of Medicine, the Mayo Clinic, Rochester, Mn (JDV); and the Department of Surgery, University of Massachusetts Medical School, MA (DE)

* To whom correspondence should be addressed. E-mail: dariush.elahi{at}umassmed.edu.

Context: Insulin is secreted in a pulsatile fashion with measurable orderliness (low entropy). Normal aging and diabetes in middle-aged patients is characterized by alterations in pulsatile insulin release.

Objectives: We undertook the current studies to determine if disruptions in pulsatile insulin release also accompany diabetes in the elderly.

Design: Two studies were performed. In the first study, insulin values were sampled every minute for 1 h under fasting conditions. In the second study, subjects underwent a 2 h hyperglycemic glucose clamp (glucose 5.4 mM above basal). From 60-120 min, insulin was sampled every 1 min. Secretory pulse analysis was conducted using a multiparameter deconvolution technique.

Setting: General clinical research center and outpatient visits

Patients: Volunteers were healthy young (n = 10, BMI=23 ± 1kg/m2, age=23 ± 1 yr) and elderly (n = 10, BMI=24 ± 1kg/m2, age=78 ± 2 yr) volunteers and elderly patients with diabetes (n = 8, BMI=28 ± 1kg/m2, age=73 ± 2 yr).

Intervention: Five of the older patients with type 2 diabetes (BMI=29 ± 1kg/m2, age=72 ± 2 yr) were treated with continuous sc GLP-1 (7-36) amide infusion for 6 weeks, and a second 2 h hyperglycemic clamp was performed.

Main Outcome Measures: Insulin burst mass, pulsatile insulin secretion and entropy

Results: Under fasting conditions, elderly patients with diabetes had a reduction in insulin burst mass (P < 0.05) that was similar to normal elderly. During hyperglycemia, elderly patients with diabetes had an even greater impairment in insulin burst mass (P < 0.05), basal (P < 0.05) and pulsatile insulin secretion (P < 0.05) than normal elderly. Approximate entropy, a measure of irregularity of insulin release, was increased to a greater extent in older diabetes patients than normal elderly, signifying loss of orderliness of insulin secretion (P < 0.05). In response to treatment with GLP-1 insulin burst mass (P < 0.05) and pulsatile insulin secretion (P < 0.05) improved significantly in elderly patients with diabetes.

Conclusions: We conclude that, alterations in pulsatile insulin release can be improved in elderly patients with diabetes by the administration of sc GLP-1




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. W. Chia and J. M. Egan
Incretin-Based Therapies in Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3703 - 3716.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society